Women’s experiences with the use of medical abortion in a legally
restricted context: the case of Argentina by Ramos, Silvina et al.
FEATUREWomen’s experiences with the use of medical abortion in a legally
restricted context: the case of Argentina
Silvina Ramos,a Mariana Romero,b Lila Aizenbergc
a Senior Researcher, Center for the Study of State and Society (CEDES), Buenos Aires, Argentina.
Correspondence: silvinaramosarcoiris@gmail.com
b Senior Researcher, CEDES, and National Scientific and Technical Research Council (CONICET), Buenos Aires, Argentina
c External Researcher, CEDES, Buenos Aires, ArgentinaAbstract: This article presents the findings of a qualitative study exploring the experiences of women
living in Buenos Aires Metropolitan Area, Argentina, with the use of misoprostol for inducing an abortion.
We asked women about the range of decisions they had to make, their emotions, the physical experience,
strategies they needed to use, including seeking health care advice and in dealing with a clandestine medical
abortion, and their overall evaluation of the experience. An in-depth interview schedule was used. The
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hotlines, ArgentinaUnsafe abortion and related mortality are both
higher in countries with narrow grounds for
legal abortion.1 By 2011, 46% of countries in the
world (91 out of 192) allowed abortion based
only on risk to the woman’s life or health, 29%
allowed abortion at a woman’s request (at least
in the first trimester of pregnancy), while five coun-
tries (Chile, El Salvador, Nicaragua, Malta and
Dominican Republic) did not allow abortion under
any circumstances.2
In 2006, it was estimated that about one mil-
lion women were being hospitalized for treatment
of complications from unsafe abortion in Latin
America.3 In 2008, according to WHO estimates,
95% of the 4.23 million abortions that took place
in the region were unsafe.1 More recently, it was
estimated that 12% of all maternal deaths in the
regional were due to complications of unsafeContents online: www.rhm-elsevier.comabortion.4 Most countries have restrictive abor-
tion laws,5 but as evidence worldwide shows,
legal prohibition does not deter women from
seeking an abortion. When faced with an unwanted
pregnancy, many women will seek an abortion,
despite condemnation and barriers that make
it difficult or impossible for them to obtain a
safe abortion.6
The development of medical technology has
made it possible for women to terminate a preg-
nancy safely, both surgically and medically. In
legally restricted contexts, the expansion of access
to and use of medical abortion has increased
considerably,7–10 due to the availability of miso-
prostol over the counter or on the black market.
In these settings, different strategies, such as
information and referral hotlines, internet pur-
chase, and pre-and post-abortion counselling areDoi: 10.1016/S0968-8080(14)43786-8 1
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organizations and women’s groups – to expand
women’s access to safe medical abortion.11,12
Medical abortion provides women with the
option of an early abortion that is safe, easily
accessible, not invasive, and allows ambulatory
care. Studies show that women prefer medical
abortion for a range of reasons: it is more natural,
it does not involve surgery or anaesthesia, it
allows for early abortion, it preserves privacy,
and women feel more in control of the abortion
process since, among other reasons, it can be
organized to fit the woman’s daily routine. For
these reasons, in most acceptability studies,
almost all the women who have used medical
abortion have said they would use it again and
recommend it to other women.8,13–16
In Latin America, women have been using
medical abortion for self-inducing abortions at
home for several decades.17,18 Of the two medica-
tions recommended by the World Health Organi-
zation for medical abortion, mifepristone is still
not available in almost any country in the region,
but misoprostol has been sold in pharmacies
since the 1980s.19,20 Misoprostol is approved in
most countries to prevent gastric ulcers but not
for gynaecological or obstetric indications, except
in six countries,* which have registered it for
some of these indications though not for abor-
tion.21 In spite of the legally restricted context
and in the absence of enforcement of the crimi-
nal law on abortion, the use of medical abortion
by women is reducing the risks of unsafe abor-
tion, thus contributing to the accomplishment
of Millennium Development Goal 5a and 5b.22
A recent literature review focused on the Latin
American region found that despite the long
tradition of academic and social research in
sexual and reproductive health, and a strong
women’s movement mobilized around the abor-
tion issue,23,24 few studies have specifically
focused on the medical abortion experience
from women’s perspective. This review also
showed that legal restrictions on access to abor-
tion and regulatory restrictions on access to
medical abortion medications result in women
lacking the appropriate information on dosage,
symptoms and efficacy of medical abortion.
The absence of counselling and support before,
during and after the abortion process also*Argentina, Brazil, Colombia, Mexico, Peru and Uruguay.
2results in women using the medication in sub-
optimal conditions.18
Abortion in Argentina is restricted by the Penal
Code, with exceptions if the woman’s life or health
is at risk, or if the pregnancy is the result of rape,
including sexual assault of a mentally disabled
woman. But even abortions on these grounds
are not guaranteed by the health system.25
Despite these restrictions, almost 400,000 abor-
tions per year have been estimated to take place
in Argentina, and complications of unsafe abor-
tion have been the leading cause of maternal
mortality for the last two decades.26,27
Legal restrictions and the absence of a culture
of abortion provision in public health services –
even for the limited grounds provided by law –
are the main barriers to accessing safe abortion.
The fact that misoprostol is not approved for
pregnancy termination adds another barrier.
Not only do women face obstacles in obtaining
misoprostol, but health professionals also have
to deal with the fact that as misoprostol is not
registered for abortion they have to resort to
using it off-label.
Women’s use of medical abortion outside of
clinical settings has therefore occurred clan-
destinely both despite legal restrictions and
because of them. Given the importance of medi-
cal abortion in reshaping the nature of abortion,
understanding women’s experiences in legally
restricted settings seems to be particularly rele-
vant.28 This article presents the findings of a
qualitative study aimed at exploring the experi-
ences of women living in Buenos Aires Metropoli-
tan Area in Argentina with the use of misoprostol
for inducing an abortion.Methodology
This was a descriptive, exploratory study. The
sample consisted of women with different medi-
cal abortion experiences in terms of the sources
of information and counselling they had to resort
to. Some of them (n=24 women) had used miso-
prostol and sought counselling or presented with
symptoms of incomplete abortion at a public
hospital in the city of Buenos Aires.† The others
(n=21 women) had used misoprostol following the
advice of a local hotline, the internet, or other
women. All of them had had their abortion at home.†The name of the hospital is not provided for confidentiality
reasons.
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who had sought counselling at a hospital were
approached by a member of the hospital’s health
team, before they were discharged, who asked if
the research team could interview them. These
interviews took place at the hospital. To reach
women who did not attend a health care facility,
snowball sampling techniques were used. Through
women’s organizations in the community and
through personal networks, we sought referrals
of women who had had a self-induced medical
abortion in the previous 12 months. In some
cases, the contact person referred more than
one woman to us. In other cases, an interviewee
referred another woman to us. In each case, the
contact person asked the women if the research
team could interview them.
An in-depth interview schedule was used to
gather information about the woman’s decision
to have an abortion and her choice of medical
abortion; how the medication was obtained;
beliefs about how the medication works; per-
ceptions of safety and efficacy; physical and
subjective experience of the abortion process;
perceptions of privacy; personal and family costs;
and the role of the health service, if any.
The protocol was approved by the WHO
Research Ethical Review Committee and by
the Comité de Ética en Investigación of CEMIC
(Centro de Educación Médica e Investigaciones
Clínicas Roberto Quirno, Buenos Aires, Argentina).
Informed consent was obtained from all the
women. Field work was conducted between
October 2011 and July 2012.
Interviews were conducted in Spanish, and
analysis was done using the original Spanish text.
Coding of the interview transcripts was conducted
independently by two members of the research
team; discrepancies in coding were discussed and
resolved by the research team. The quotes used
here were translated into English. All names used
are fictitious to protect participants’ anonymity.
Our aim, as described in this paper, was to
explore the diversity of women’s experiences,
the range of decisions, emotions, and physical
accounts and strategies, including seeking health
care, that women went through in dealing with a
clandestine medical abortion, and their overall
evaluation of the experience. We also wanted
to find out whether the experience of medical
abortion might be different if the woman had
received medical advice and care before or after
the abortion. We discuss the implications of thesefindings for women’s health and well-being, and
examine how the findings should be used to influ-
ence future strategies to improve access to safe
medical abortion in legally restricted contexts.Findings
The 45 women interviewed were aged 18–40 years;
60% had completed basic education (seven or
more years of schooling). One third of them were
living with their partners at the time of the inter-
view. Sixty per cent of them had children, ranging
from one to nine.
We identified four stages in the women’s experi-
ences. Firstly, how the decision to terminate the
pregnancy was taken, including the search for
information and the reasons for choosing medi-
cal abortion. Secondly, how the medication was
obtained, including access to a prescription and
the purchase of the tablets. Thirdly, how the tablets
were used, including the search for information
about how to use them (dosage, interval, side
effects and danger signs). Finally, the post-abortion
stage, once the process was over, whether or not
the woman sought medical advice, and the
woman’s reflections on what had happened.
The decision to terminate a pregnancy
using misoprostol
The choice of medical abortion was the result
of the women comparing different options for
resolving their pregnancy. In this process, the
advantages of using pills for an abortion were
a key factor: pills were more comfortable because
they could be used at home and with a significant
other person at the woman’s side; they were less
risky; the medication was safe and more effective;
it did not require undergoing a surgical proce-
dure. The cost of the pills compared to the cost
of a surgical abortion was not reported as an
important barrier or as an advantage.
“It seems less risky to me. Yes, it seems safer, and
less.... I don’t know, I feel that maybe [surgical
abortion] is too much of an intervention into your
body. I used the pills instead, I did it at home,
with the people I love, and maybe it is less hard
than the curette.” (Laura, 25)
“I picture myself in just any place, with any doctor,
not knowing whether he is really a doctor or not,
and it seems to me like butchery. I have a friend
who did that and she came out totally drugged
from anaesthesia, crawling on the floor in an3
S Ramos et al. Reproductive Health Matters 2014;Supplement(43):1–12empty apartment, you see, it is really not good, no
support at all, you never even know who per-
formed it…” (Lucía, 28)
For most of the women interviewed, the informa-
tion needed to make the decision whether to use
misoprostol was obtained by contacting different
sources, primarily friends and relatives. However,
the information obtained was often incomplete
and did not fully satisfy their expectations, thus
making them resort to more than one source
until they felt they had received the information
necessary to move on. Trust in the method’s safety,
instilled by the sources consulted, was the deter-
mining factor in deciding to use misoprostol for
18 of the 45 women.
Those women who were able to consult health
services that are well known for their commit-
ment to women and quality of care felt particu-
larly comfortable with the abortion process. On
top of that, the interaction with friendly pro-
viders, who not only gave proper information
but also listened to them and paid attention to
their concerns in a respectful way, made them feel
legitimized in their decision. For several women,
the internet played a significant role, mostly for
those who accessed a local hotline and its printed
materials,* whose information was a kind of “one-
stop shopping”. They described this source as
accessible, comprehensive and accurate.
“Once I realized I was pregnant I started asking
friends who were older than me if they knew how
to end it… They told me about the pills and other
methods, but they said: ’If you are going to do it,
play it safe! ’ So, I did not think about another
alternative, I trusted them since they knew what
they were talking about.” (Claudia, 21)
“I asked a friend who told me that X hospital
was friendly, that she sent girls there… And then
there are books, that one from the Lesbians and
Feminists who support legal and safe abortion,
which I borrowed. I read it, and found it was
safe. I already had information from my friends
in Chile who had done it. And so, I made the
decision.” (Taira, 31)*We refer to “Todo lo que querés saber sobre cómo hacerse
un aborto con pastillas”, Lesbianas y Feministas por la




4Getting hold of the medication
It took the women one to two weeks to obtain a
supply of the tablets. The complexity of this
endeavour depended on getting the prescription
needed to purchase it; having contacts who could
identify which pharmacy to go to; finding a phar-
macy that would sell it; having enough money;
and getting the support of friends and/or family.
In Argentina, a filled-in prescription form, hand-
written and dated by a health professional, is
required to purchase misoprostol. Personal con-
tacts and word of mouth were particularly impor-
tant in this respect. Given the burden of trying to
obtain a filled-in prescription form, many women
tried different strategies to get the medication
without one. In the end, 21 women obtained a
prescription from a public health service well
known for providing counselling, while 11 women
bought the medication at a pharmacy without a
prescription. Six turned to a physician friend
or relative who provided the prescription, five
got the pills directly from friends or relatives,
and two women bought the medication through
the internet.
“I went to several pharmacies, together with a
friend of mine; we went from pharmacy to phar-
macy, and we told the pharmacist: ‘Look I have
this problem, I need your help but I do not have
a prescription.’” (Yamila, 18)
“The hardest part was getting the prescription…
in the end I got it through a friend of a friend
who was a doctor… but before that I made sev-
eral appointments with gynaecologists trying to
find a friendly doctor who would give me a pre-
scription.” (Gabriela, 25)
Those who could not get the name of a pharmacy
they could rely on consulted the pharmacies in
their own neighbourhood as a first step, since
knowing the pharmacy staff was perceived as an
asset that might make the purchase possible.
Given the fact that misoprostol is not registered
for abortion, buying the medication for that pur-
pose requires making an illegal act look as if it
were a legal one. For the women in this study,
this meant using strategies to avoid any “what
is it for” questions on the part of the pharmacist.
For example, some of the women asked an older
person to purchase the medication, making it
sound like they had a gastric ulcer problem.
Others asked for the prescription to be written
up on behalf of a man.
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partner instead of me. He said: ’Well, I will go
and purchase it with my good neighbour face.
I can always say I have tendinitis, or whatever…”
(Victoria, 33)
Even though almost all the women in the
study had financial limitations, the cost of
the medication was not perceived as an insur-
mountable problem, particularly when com-
pared to the perceived cost of a surgical abortion.
It is worth noting that the women pondered
both cost and safety together when deciding
for a medical abortion.
“The reason why I would recommend it is
because of the greater possibility of economic
accessibility, compared to the cost issue with
surgical abortion. You can choose between this
[medical abortion] and other clandestine kinds
of abortions, which are riskier. That makes a
difference. I can tell you that at the level of the
poor middle class, or whatever it is that we are,
we know that surgical abortions are currently risky
because of the conditions in which they are per-
formed. This is a cheaper and safer possibility.”
(Yamila, 21)At the end, half of the women had to rely on
contacts in their personal networks to finally
get hold of the medication.
“My sister got me the pills. She works in a social
organization that provides the pills for women
who want to have an abortion. The organization
gets the pills through another organization which,
as far as I know, has a contact with someone
who works in a laboratory.” (Camila, 22)
“A friend of mine knows because a friend of hers
knows. I said to her: ’Please, when you talk to
her, ask where she bought them. ’ She did me this
favour, she asked her and she said she had
bought the pills from a lady. And off we went,
she just walked in, bought them and gave them
to me.” (Norma, 30)Using the medication
The restricted legal context in which abortions take
place in the country influences the type and
quality of information available.18 Half of the
women felt confident about how to use the pills,
mostly those who had been advised by a health
provider before the abortion or had obtained5
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Nevertheless, the interviews showed that the
women’s knowledge of what to expect and how
the medication works was incomplete and frag-
mented, and even physicians were not always
perceived as reliable sources.
“Doctors themselves give different information.
I received very different information. One said
that I had to take only 4 pills and that would
cause the abortion, another said that I should
take all 12 of them; another said that I should
take 4 pills and maybe 24 hours later the other 4.
And that worried me.” (Norma, 30)
“A friend of mine asked different feminist orga-
nizations and she got information but piece by
piece… People were scared to give her the infor-
mation directly and they found it hard to give
her a phone contact. Or they told her that there
was a pill and it was not illegal to get it. All the
information they gave her was wrong. Then, I
found a website where I found a very useful book
about abortion with pills, where to get it and the
steps to follow.” (Gabriela, 25)
Routes of administration used were vaginal, oral,
or a combination of both. Physicians sometimes
recommended not using the vaginal route so that
there will be no trace of the medication after-
wards if the woman is examined, e.g. if she has
complications of any kind. Women reported dif-
ferent regimens but the most frequent one was
4 pills every 3 hours. Women were particularly
concerned about the number of pills and the
interval between doses, which was the least clear
information they could obtain.
“My main doubt was when to repeat the dose …
whether I was losing it or not because the infor-
mation I had said that if you had a big loss
and you had to use two menstrual pads every half
hour then you had to go to hospital. But I had a
normal period so I was not sure. Then, I bled for
15 days so I went to a clinic and the ultrasound
showed I still had something inside, so I repeated
the dose, I used 4 pills.” (Andrea, 33)
All the women took the medication at home,
on a day and at a time of day most convenient
for them, which made them felt more at ease.
They chose the night time, when children
were asleep, or weekends when they had some
time to rest, and interferences and demands
were reduced.6“I used it during the weekend, because [the doctor]
told me that in two days, three at most, it would
be done. So, I said, on the third day, I will be
ready to go back to work.” (Gabriela, 43)
Two-thirds of the women went through the abor-
tion process in the company of someone close to
them (partner, friend or relative), who they
trusted. This was particularly highlighted by
them as a unique advantage of medical abortion.
“You can do this at home, it allows you to have
somebody there that you trust and can get sup-
port from.” (Lucía, 28)The physical experience
For most of the women the abortion itself was
experienced either as a normal menstruation or
a more intense one. This created the perception
that the abortion was close to a “natural process”
and made them cope better with their anxiety
and fears.
“It was like a normal menstruation. You think it
will be like heavy bleeding or something like that,
but it was very light and then it stopped… I was
worried whether everything would turn out fine,
I didn’t know how my body would handle it…
but no, it was actually great.” (Karina, 36)
The bleeding and expulsion were recognized as
key signs. In fact, 16 women said that through
the bleeding they could confirm that the abor-
tion process had started and was ongoing.
Women also reported other physical symptoms,
such as pain (24), expelling blood clots (9), con-
tractions (5), chills (3), vomiting (3), buzzing in
their ears (1), and diarrhoea (1). Though the
women felt less pain than expected, dealing with
it depended on whether they had been pre-
viously informed about the side effects, and
whether somebody kept them company.
“I was with my partner, he was with me because as
far as I understood it, you cannot take the medica-
tion if you are alone, just in case, you know… that
is what my doctor told me…. It was different from
what I had expected, less tragic… I thought that
the pain was going to be stronger and that I
was going to be even more worried.” (Lucía, 25)
Only 12 of the 45 women used painkillers, mostly
those who had been previously advised to do
so by a health professional. Fear about stop-
ping the abortion process, as well as the belief
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the main reasons why women rejected the use
of analgesics.
Despite having some notion about what symp-
toms they should expect after taking the pills,
and how to move on consequently, many of the
women lacked information about how the drug
acts and what it does in the body. These ideas
were expressed as:
“Whatever is there is dissolved/unfastened.”
“There are little pieces of tissue.”
“It has to do with chemical reactions that make
the body expel the embryo.”
“It produces contractions.”
“It dilates the uterus.”
“It changes your hormones.”
“Pills get there and explode.”
“I had a revolution in my belly.”
“The pills cut the oxygen.”
The emotional experience
Although all the women had decided to have an
abortion, all of them went through the process
with negative emotions, even those who were
confident about the medication. Fear of heavy
bleeding (8), guilt and remorse (8), uncertainty
of not knowing whether the medication had
been correctly taken (6), dread of becoming infer-
tile (6), careless for getting pregnant (6), sadness (5),
annoyed about having to deal with health care
providers and confessing the abortion (4), fear of
dying (3), worries about coping with daily routine
(2), shame for killing a baby and neglecting their
kids, (3) were all part of women’s accounts.
On the other hand, relief and satisfaction with
having solved the problem, and a feeling of self-
confidence about the decision taken were posi-
tive emotions associated with the abortion
experience for some women. For these women,
having information on fetal growth, and the
practical sense of “having solved” a vital prob-
lem counterbalanced guilt and remorse, which
appeared to be underlying emotions for almost
all the women interviewed.
“The first fear, maybe the strongest one, is that of
guilt. It is this idea of killing a life, let’s say, this
thing that results from a Christian upbringing,
which actually I didn’t have. But also, I had a
feeling of relief, of being able to do it. You can
never say that it is a joy, it cannot be said that
you are happy when doing what you have todo, but there is this idea that I wanted this, that
I wanted to do it.” (Natalia, 33)
Fears and anguish were also better handled when
women had a support network, including a health
care provider who would be responsive to doubts
or a significant person who would stay by her
throughout the abortion process.
“What I remember is my partner’s company, we
were living together and my house was the
place we chose to do it. He was there; he took
care of me and also took care of my physical
pain… I never felt that things were out of con-
trol.” (Natalia, 33)
The experience with the health service
Previous consultation with the hospital where
some of the women were contacted for the study
shaped their expectations about medical abortion.
Those who had received counselling there were
above all pleased and very surprised by the fact
that a public health facility was willing to guide
them through the process, give relevant informa-
tion, ask no questions, provide comfort, reassure
them of the safety of the method, and support
their decision. All these features were pointed
out as especially valuable and made them feel
more at ease with their decision to abort and
the abortion process itself.
“To feel comforted, to feel guided about what
to do next, about where to get the medicine, to
have the prescription problem solved, to receive
information on the price, all these issues… and
not being condemned, looked after… these truly
mattered to me.” (Laura, 25)
“At first I was scared to come to the hospital…
I had already experienced going to public hospi-
tals to ask for the morning-after pill or to ask
for condoms and being treated like a murderer…
but once there, the easiest thing was being able
to talk to the women doctors. They are very
friendly women; it was easy talking to them. I
thought it would be harder. These ladies are very
nice and you can trust them and tell them any-
thing, because they will not make a big deal out
of it. And for me that was really essential.”
(Lucia, 23)
“They opened the door for me. I was very nervous,
I had an ultrasound, they said how long I was
pregnant… that I had time to think it over, they
calmed me down and reassured me everything7
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that the risk of dying was very, very low. They
advised me to come back; that they would be
waiting for me.” (Debora, 23)
For three of the women who had had no pre-
vious counselling from a health professional,
what they thought were alarming symptoms −
fever, heavy or lengthy bleeding, unbearable
pain, absence of bleeding – triggered the deci-
sion to go to hospital. All three expected a nega-
tive response from the hospital, based on their
own and other women ’s experiences. They
assumed the health service would not be recep-
tive to their needs because of what they had
done. Fear about being mistreated and/or reported
to the police were overcome by the even stronger
fear of dying, however. Once they were admitted,
these expectations were replaced by the distressing
reality of being left alone in a room or being put
into the same room as women in labour or women
with their newborn babies next to them, because
the hospitals do not have a separate space for
women with abortion complications.
“The fear I felt was because I was in a room
alone, and in the next room there were women
giving birth. There was this girl who was giving
birth and I heard everything. I told myself: ’I want
to die. ’ There was a clock there, I kept staring at
it, my sister called me every 50 seconds because
they only let them come in for a second. They
were not allowed to visit me.” (Lucia, 28)
“You are in the same room with all the mothers.
They keep talking about the baby, about the
belly, blah blah blah… So I was fine, but it
was impossible not to feel anguish.” (Andrea, 21)The “abortion is over”: assessment of
the experience
At the end of the interview, women were asked
to assess their experience as a whole and its
positive and negative aspects, the impact it had
on them and how they saw it for women in gen-
eral. Some of the women touched on aspects of
the method itself and what it allows and also
the circumstances in which their abortion expe-
rience had taken place, which they felt needed
to be understood together. Many of them men-
tioned both good aspects and negative ones,
recognising the ambivalence in both the situa-
tion and the experience.8“If you know the risks, if you have good informa-
tion, and someone by your side, the pills allow
you to keep the experience private. The decision is
always a private one, and using the pills means
that you are able to do it in your own way, when
you want, with the people you want, and that
is priceless. But not all women have access to
these conditions… and sometimes another method
is chosen − because life is different for each
woman.” (Ana, 29)
“The method doesn ’t matter as long as it is safe
and it is backed by someone, by a professional.
The method doesn ’t matter; it does matter how
you reached it, what matters is to know what to
expect and to have information…” (Claudia, 24)
“With [the pills] you don ’t take any risks, as you
do when you are in the hands of someone you
don ’t know, who will charge you lots of money
because he doesn ’t care… you are not cared
for in such hands and you can even catch some-
thing.” (Lucía, 28)
“When I decided to do it, I thought: ’It ’s relatively
cheap, you are at home, you can be with some-
one, and you are not in a clandestine place. After-
wards, it took so long that I thought that I should
have decided otherwise. Because with that other
way, you end it in the same day, you leave and
that ’s it. Begins and finishes the same day, you
get checked, but when that shitty moment passes,
it ’s over. But this way it keeps going on and you
don ’t know whether to repeat the pills or not.”
(Andrea, 21)
The circumstances in which the abortion took
place, the clandestine conditions and the conse-
quent risks, and the quality of information they
could get, were particularly significant for some
of the women.
“Other options are more complicated because you
need a physician to intervene, a physician who is
committing a felony; you are engaged in a per-
verse relationship because you are bribing him
to put his license at risk… so in that sense, pills
are a million times better.” (Victoria, 33)
“I know women who it failed for. For me it
depends on how you manage it and what you
know beforehand… I know people who tried with
the pills over and over and nothing happened.
Luckily for them, the babies were fine because
there was the chance for something to happen.
Information really matters.” (Claudia, 24)
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autonomy to make decisions. The option of a pri-
vate process for pregnancy termination, with the
interference of no one else, was particularly valued.
“The pills can change your life, being able to
decide what you want to do with your body…
I think they are like birth control pills, you take
them and you don’t have to explain why you
take them, they give you autonomy and a privacy
which even the loneliest of women in the world,
even one who has nobody she can trust, can still
do it. So I believe this aspect, autonomy, is essen-
tial because, after all, it is your body. I think the
other options always include a third party with
whom you have to negotiate and whenever you
have to negotiate, there is something to lose…
Once you have the pills in your hands you can do
whatever you want.” (Victoria, 33)Conclusions
This study explored women’s experience with
medical abortion in a legally restricted setting.
As with a number of other countries in Latin
America, the situation related to abortion in
Argentina has been changing in recent years
due to judicial rulings in favour of women’s
access to abortions that are legal on existing
grounds of risk to life or health, and rape, and
the introduction of certain public policy changes,
particularly norms issued to regulate access
to legal abortion on these grounds.23,29,30 At
the same time, the alternative of home use of
misoprostol, coming from women ’s groups,
social organizations and health teams at cer-
tain public health services, has reached women
with unwanted pregnancies. Supporting this
are local hotlines and websites providing accu-
rate and gender-sensitive information and coun-
selling, as well as referrals to friendly health
services;31 community-based organizations car-
rying out educational activities and providing
informational materials, reaching out to women
and providing support;32 public health services
counselling women using a harm-reduction
approach;33 an open cultural climate for debate
on abortion;34–36 and the more extensive use of
misoprostol for pregnancy termination, often dis-
covered by women through word of mouth.33,36
The findings reported here should therefore
be interpreted in the light of this changing con-
text. The unprecedented window of opportunitycreated by misoprostol use sits side by side with
the historical barriers to access safe abortion,
legally or not. Women are benefiting from the
new scenario but still live with the deeply
rooted cultural background of illegality, which
makes them suffer from social stigma and emo-
tional barriers that limit their acceptance of the
decision to have an abortion.
The findings show that women perceive many
advantages to medical abortion. As many other
studies in the Latin American region have shown,
the women in this study greatly appreciated the
possibility of keeping their abortions private; of
being able to choose the day, place and time to
use the pills; the safety of having the abortion
without the intervention of unknown people;
the secure feeling of going through a physiologi-
cal process; and the chance of being looked after
by someone they chose.
The fact that the women had to rely on them-
selves in a clandestine setting meant that infor-
mation and counselling were critical.16,26 The
women accessed information from different
sources and were particularly concerned when
those sources did not provide the same informa-
tion, or it was fragmented or inaccurate. The
information they managed to obtain made them
trust the method enough to go forward with it
but, at the end of the day, they sometimes felt
that the knowledge they had was not enough,
causing a distressing sense of uncertainty. Although
more information is available now compared to
the past,16 it still seems to be much less than
women need. In addition, it does not speak about
the wide range of aspects of the abortion process
that women are concerned about: the extent of
the bleeding, whether and when to repeat the
dosage or not, how to assess the clots, how to
cope with fear, anxiety, pain and guilt, among
other aspects.
Women actively searched for counselling to
support them to make a decision and/or carry
out the abortion. They found it from various
sources: a hotline, relatives and friends, printed
material, and also health professionals.8 The par-
ticularities of the method, combined with the
legal restrictions on health professional involve-
ment, puts the abortion in women’s hands. The
diversity of groups and individuals currently com-
mitted to supporting safe abortion also makes
counselling, which is essential, more available.
At the same time, the hotline and its
information materials were highly valuable9
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seemed more assertive and resourceful in using
the internet and managing with printed mate-
rials. For women who felt more vulnerable,
face-to-face contact and reassurance from a
friendly health care provider better suited their
needs. Moreover, the “moral authority” of
health care providers helped to dissipate their
distress and bring legitimacy to their situation
and decisions.
Our findings show that the women involved
and relied on partners, family and/or friends
during the abortion process. The “nature” of
medical abortion and the women’s wish to have
someone by their side was nurturing for them.8,26,37
Although recent studies in Latin America argue
that women use medical abortion because they
have no other alternative, we have shown that
the women in this study chose medical abortion
after a thoughtful process of decision-making.8,37,38
The final decision was taken once the advantages
and safety of the pills were clear.
Although this study was small and cannot be
taken as representative, the findings show that
despite the legally restrictive setting, women
were accessing information, counselling and
misoprostol, and at the end, deciding whether
to have an abortion and able to act on their
decision, whether or not they had health pro-
fessional support. They found this method chal-
lenging but also acceptable and affordable.
Nevertheless, they also expressed many doubts
and uncertainties, not all explained by the10clandestine environment. The fact that the use
of medical abortion in this setting was in their
own hands put a heavy burden on some of
them. A lot of self-confidence would be needed
to go through this process without hesitation.
Efforts to improve abortion law, policy and
service provision in Argentina in order to ensure
the best possible conditions for use of medical
abortion by women should be redoubled. The
availability of mifepristone as well as miso-
prostol should be approved and an enabling
environment created. At the same time, since
not all women and not all life experiences
and circumstances are the same, choice of abor-
tion method and information sources should be
a priority.
Acknowledgements
We are grateful to all the women who shared
their experiences and trusted us in reporting such
a significant moment of their lives. We want to
thank the Chief of Service and staff of the hospital
that introduced us to women. Without their help
the study would not have been possible. We
greatly appreciate the commitment and sensitivity
of Ana Aguilera, Sonia Ariza, Paula Bilder and
Tamar Finzi in conducting the interviews. This
project was possible thanks to the support of the
UNDP/UNFPA/WHO/World Bank Special Pro-
gramme of Research, Development and Research
Training in Human Reproduction – Social Science
and Operations Research in Sexual and Repro-
ductive Health, Project A 65735.References
1. Ahman E, Shah IH. Unsafe Abortion: Global and 5. Guttmacher Institute. Hechos sobre el aborto en
Regional Estimates of the Incidence of Unsafe Abortion
and Associated Mortality in 2008. Geneva: World
Health Organization, 2011. http://www.who.int/
reproductivehealth/publications/unsafe_abortion/
9789241501118/en/.
2. Turquet L. In Pursuit of Justice. New York: United
Nations Entity for Gender Equality and the Empowerment
of Women, 2011. http://progress.unwomen.org/pdfs/
EN-Report-Progress.pdf.
3. Singh S. Hospital admissions resulting from unsafe
abortion: estimates from 13 developing countries.
Lancet 2006;368(9550):1887–92.
4. Guttmacher Institute. Facts on induced abortion
worldwide. January 2012. http://www.guttmacher.org/
pubs/fb_IAW.pdf.América Latina y el Caribe. Enero de 2012. http://www.
guttmacher.org/pubs/IB_AWW-Latin-America-ES.pdf.
6. Cohen S. Facts and consequences: legality, incidence
and safety of abortion worldwide. Guttmacher Policy
Review 2009;12(4). http://www.guttmacher.org/pubs/
gpr/12/4/gpr120402.html.
7. Winikoff B. Acceptability of medical abortion in early
pregnancy. Family Planning Perspectives 1995;27(4):
142–8,185.
8. Laufaurie MM, Grossman D, Troncoso E, et al.
Women’s perspectives on medical abortion in Mexico,
Colombia, Ecuador and Peru: a qualitative study.
Reproductive Health Matters 2005;13(26):75–83.
9. Beckman LJ, Harvey SM. Experience and acceptability
of medical abortion with mifepristone and misoprostol
S Ramos et al. Reproductive Health Matters 2014;Supplement(43):1–12among US women. Women’s Health Issues 1997;7(4):
253–62.
10. Winikoff B, Sivin I, Coyaji K. The acceptability of
medical abortion in China, Cuba and India. International
Family Planning Perspectives 1997;23:73–78,89.
11. International Planned Parenthood Federation. Guía
para difundir y promover el modelo de reducción de
riesgos y daños frente al aborto provocado en
condiciones de riesgo. www.ippfwhr.org/sites/default/
files/guia%20IPPF%20final.pdf.
12. Gomperts RJ, Jelinska K, Davies S, et al. Using
telemedicine for termination of pregnancy with
mifepristone and misoprostol in settings where there is
no access to safe services. BJOG: An International Journal
of Obstetrics and Gynaecology 2008;115(9):1171–5.
13. Gynuity Health Projects. Providing medical abortion
in low-resource settings: an introductory guidebook.
New York: Gynuity Health Projects, 2009. http://gynuity.
org/downloads/clinguide_maguide2nd_edition_en.pdf.
14. Swica Y, Raghavan S, Bracken H, et al. Review of the
literature on patient satisfaction with early medical
abortion using mifepristone and misoprostol. Expert
Review of Obstetrics & Gynecology 2011;6(4):451–68.
15. Winikoff B, Sivin I, Coyaji KJ, et al. Safety, efficacy, and
acceptability of medical abortion in China, Cuba, and
India: a comparative trial of mifepristone-misoprostol
versus surgical abortion. American Journal of Obstetrics
and Gynecology 1997;176(2):431–7.
16. Zamberlin N, Romero M, Ramos S. Latin American
women’s experiences with medical abortion in settings
where abortion is legally restricted. Reproductive
Health Journal 2012;9(1):34. http://www.reproductive-
health-journal.com/content/pdf/1742-4755-9-34.pdf.
17. Barbosa R, Arilha M. The Brazilian experience with
Cytotec. Studies in Family Planning 1993;24(4):236–40.
18. Costa SH. Commercial availability of misoprostol
and induced abortion in Brazil. International Journal of
Gynecology & Obstetrics 1998;63(Suppl 1):S131–9.
19. Távara Orozco L, Chávez S, Grossman D, et al.
Disponibilidad y uso obstétrico del misoprostol en los
países de América Latina y el Caribe. Lima: CLACAI, 2011.
http://www.clacaidigital.info:8080/xmlui/handle/
123456789/173.
20. Consorcio Latinoamericano contra el Aborto Inseguro
(CLACAI); Centro de Estudios de Estado y Sociedad (CEDES);
Federación Latinoamericana de Sociedades de Obstetricia
y Ginecología (FLASOG). Misoprostol: regulaciones y
barreras en el acceso al aborto legal. 2013. http://www.
clacaidigital.info:8080/xmlui/handle/123456789/489
21. Gynuity Health Projects. Map of misoprostol approval,
2011–2013. http://gynuity.org/downloads/mapmiso_sp.pdf.
22. Gordon P, Boler T, Burgin J, et al. What women want:
meeting the global demand for medical abortion. London:Marie Stopes International, 2010. http://www.mariestopes.
org/sites/default/files/What-Women-Want-Summary.pdf.
23. Asociación por los Derechos Civiles. Aborto no punible.
El fallo “F., A.L. s/ medida autosatisfactiva” ¿qué
obtuvimos y qué nos queda por obtener? http://www.
clacaidigital.info:8080/xmlui/handle/123456789/425.
24. Mario S, Pantelides EA. Estimación de la magnitud
del aborto inducido en la Argentina. Notas de Población
2009;87:95–120.
25. Romero M, Ábalos E, Ramos S. La situación de la
mortalidad materna en Argentina el Objetivo de
Desarrollo del Milenio 5. Hoja Informativa n° 8. Buenos
Aires: OSSyR, Observatorio de Salud Sexual y
Reproductiva, marzo de 2013. http://www.ossyr.org.ar/
pdf/hojas_informativas/hoja_8.pdf.
26. Lie M, Robson S, May C. Experiences of abortion: a
narrative review of qualitative studies. BMC Health
Services Research 2008;8:150. http://www.
biomedcentral.com/content/pdf/1472-6963-8-150.pdf.
27. Lafaurie MM, Grossman D, Troncoso E, et al. El aborto con
medicamentos en América Latina. Las experiencias de las
mujeres en México, Colombia, Ecuador y Perú. Population
Council y Gynuity Health Projects, 2005. http://www.
clacaidigital.info:8080/xmlui/handle/123456789/50.
28. Espinoza H, Ellertson CH, García S, et al. Medicamentos para
la interrupción de la gestación: una revisión de la literatura
y sus posibles implicaciones para México y América
Latina. Gaceta Médica de México 2002;138(4):347–56.
29. Pecheny M. Yo no soy progre, soy peronista. In: Bergallo
P, ed. Aborto y Justicia Reproductiva. Buenos Aires:
Editores del Puerto, 2011. p.91–114.
30. Ramos S, Romero M, Arias Feijoó J. El aborto inducido en
la Argentina: ¿un viejo problema con un nuevo horizonte?
In: Bergallo P, editor. Aborto y Justicia Reproductiva.
Buenos Aires: Editores del Puerto, 2011. p.57–90.
31. Lesbianas y feministas por la descriminalización del
aborto. Todo lo que querés saber sobre cómo hacerse un
aborto con pastillas. Buenos Aires: Editorial El Colectivo,
2010. www.abortoconpastillas.info.
32. La Revuelta. Cómo hacerse un aborto con pastillas. 2012.
http://sincloset09.wix.com/aborto-misoprostol.
33. Vázquez S, Gutiérrez MA, Calandra N, et al. El aborto en la
adolescencia. Investigación sobre el uso de misoprostol para
la interrupción del embarazo en adolescentes. In: Checa S,
editor. Realidades y coyunturas del aborto. Entre el derecho
y la necesidad. Buenos Aires: Paidós, 2008. p.277–97.
34. Carbajal M. El aborto en debate: aportes para una
discusión pendiente. Buenos Aires: Paidós, 2009.
35. Zurbriggen R, Anzorena C. El aborto como derecho
de las mujeres. Otra historia es posible. Buenos Aires:
Ediciones Herramienta, 2013.
36. Zamberlin N, Gianni MC. El circuito del misoprostol:
un estudio de las respuestas a la demanda de11
S Ramos et al. Reproductive Health Matters 2014;Supplement(43):1–12medicamentos abortivos en farmacias privadas. Revista
Medicina 2007;67(Suppl.1):67.
37. Carril Berro E, López Gómez A. Entre el alivio y el dolor:
mujeres, aborto voluntario y subjetividad. Montevideo:
Trilce, 2008. http://www.hacelosvaler.org/2008/esp/
publicaciones/entre_el_alivio_y_el_dolor.pdf.Résumé
Cet article présente les conclusions d’une étude
qualitative de l’expérience d’habitantes de l’Aire
métropolitaine de Buenos Aires, Argentine, qui
ont utilisé le misoprostol pour provoquer un
avortement. Nous avons demandé aux femmes la
portée des décisions qu’elles ont dû prendre, leurs
émotions, l’expérience physique, les stratégies
auxquelles elles ont eu recours, notamment
demander des conseils de santé et gérer un
avortement médicamenteux clandestin, et leur
évaluation globale de l’expérience. Un plan
d’entretien approfondi a été utilisé. Les femmes
avaient utilisé le misoprostol et demandé des
conseils ou des soins dans un hôpital public
(n=24) ou bien elles avaient utilisé le misoprostol
selon les conseils d’une ligne d’assistance, les
informations sur Internet ou les conseils d’autres
femmes (n=21). Quatre étapes ont été identifiées
dans l’expérience des femmes : comment elles
ont décidé d’interrompre la grossesse, comment
elles ont obtenu le médicament, comment elles
ont pris les comprimés et des réflexions sur l’issue,
qu’elles aient ou non demandé des conseils
médicaux. La sécurité et la confidentialité sont
des facteurs déterminants de la décision de
pratiquer un avortement médicamenteux. L’accès
aux médicaments était le principal obstacle,
nécessitant une ordonnance ou une pharmacie
compréhensive. Les informations correctes sur le
nombre de comprimés à utiliser et les intervalles
de dosage étaient les moins faciles à obtenir et
ont suscité des inquiétudes. La possibilité de
choisir un moment d’intimité et d’être accompagnée
par un proche a été soulignée comme un avantage
unique de l’avortement médicamenteux. Il
faudrait redoubler d’efforts pour améliorer les
lois, les politiques et la prestation de services
d’avortement en Argentine afin de garantir les
meilleures conditions possibles pour l’utilisation
de l’avortement médicamenteux par les femmes.
1238. Silva M. Lo que cuentan las mujeres. Vivencias y
trayectorias terapéuticas de usuarias de los servicios de
interrupción voluntaria del embarazo en Montevideo,
Cerro Largo y Paysandú. Montevideo: Médicos del
Mundo, 2014. http://www.clacaidigital.info:8080/xmlui/
handle/123456789/536.Resumen
Este artículo presenta los hallazgos de un estudio
cualitativo que explora las experiencias de las
mujeres que viven en el Área Metropolitana
de Buenos Aires, en Argentina, con el uso de
misoprostol para inducir un aborto. Les preguntamos
a las mujeres acerca de una variedad de
decisiones que tuvieron que tomar, sus emociones,
la experiencia física, las estrategias que necesitan
utilizar, tal como buscar consejos sobre servicios
de salud y para lidiar con un aborto con
medicamentos clandestino, así como sobre su
evaluación general de la experiencia. Se utilizó
un programa para entrevistas a profundidad. Las
mujeres habían usado misoprostol y buscado
consejería o atención en un hospital público
(n=24), o habían usado misoprostol basándose
en los consejos de una línea local de atención
telefónica, información del internet o de otras
mujeres (n=21). Se identificaron cuatro etapas
en las experiencias de las mujeres: cómo
tomaron la decisión de interrumpir el embarazo,
cómo obtuvieron el medicamento, cómo usaron
las tabletas, y sus reflexiones sobre el resultado
independientemente de que hayan o no hayan
buscado consejos médicos. La seguridad y
privacidad fueron clave para decidir usar el
método de aborto con medicamentos. El acceso
al medicamento fue el principal obstáculo, que
requirió una receta o una farmacia con personal
amigable. La información correcta sobre el
número de tabletas a usar y los intervalos de
dosis fue la manera menos fácil de obtener y
causó inquietudes. La posibilidad de escoger un
momento de privacidad y estar acompañada
de una persona cercana se destacó como una
ventaja única del aborto con medicamentos.
Es imperativo reduplicar los esfuerzos por
mejorar la ley, política y prestación de servicios
referentes al aborto en Argentina a fin de
asegurar las mejores condiciones posibles para
el uso del aborto con medicamentos por parte
de las mujeres.
